William Blair initiated coverage of Xencor (XNCR) with an Outperform rating. The firm believes the biopharmaceutical industry is entering a ...

Bassil Dahiyat, CEO of Xencor, told Endpoints: “We are one of many companies made up of a large percentage of immigrant staff, highly talented and trained. We cease to function without ...

Style Claims Must Be Supported by an Adequate Written Description U.S. patent claims have a preamble, and, in most cases, the ...